Moreover, the expansions of monoclonal and oligoclonal T cells carrying clonal TCRγ and δ gene rearrangements have been observed in CML patients at diagnosis and during dasatinib therapy [26, 27]. The gene discussed is TRGC1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.